Spondyloarthritis Research And Treatment Network
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2015 | 724,614 | 0 | 724,614 | — | — |
| 2016 | 568,637 | 274,223 | 294,414 | 43.7 | 0% |
| 2017 | 502,495 | 293,188 | 209,307 | 49.4 | 0% |
| 2018 | 669,851 | 250,192 | 419,659 | 73.6 | 0% |
| 2019 | 2,005,831 | 451,796 | 1,554,035 | 79.2 | 0% |
| 2020 | 1,051,122 | 451,083 | 600,039 | 99.3 | 0% |
| 2021 | 903,973 | 1,434,698 | −530,725 | 26.8 | 0% |
| 2022 | 1,197,948 | 2,108,521 | −910,573 | 13.0 | 0% |
| 2023 | 1,072,855 | 820,283 | 252,572 | 41.6 | 14% |
In its most recent public year (2023), this organization brought in $252,572 more than it spent. Its reserves stood at about 41.6 months of spending. Staff pay was 14% of spending. $245,850 of its net assets are donor-restricted.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Spondyloarthritis Research And Treatment Network's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works